Primary record
(2R,3S)-2-[acetyl(methyl)amino]-N-[(2S,3S)-1-{[(2S,3R)-3-hydroxy-1-({(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}amino)-1-oxobutan-2-yl]amino}-3-methyl-1-oxopentan-2-yl]-3-methylpentanamide
- 库存
- 5,457 克
- 纯度
- 98.3 %
- CAS
- 134381-21-8
化合物标识与属性
- CAS
- 134381-21-8
- PubChem CID
- 11226684
- SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@]1(CO1)C)NC(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C
- Canonical SMILES
- CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1)[C@@H](C)O
名称与同义词
- epoxomicin
- EPOXOMYCIN
- 134381-21-8
- BU-4061T
- Epoxomicin solution
- EPOXOMICIN [MI]
- RefChem:137356
- UNII-Y0900I3U8U
- C28H50N4O7
- Y0900I3U8U
- SCHEMBL73907
- DTXSID5044073
- BU 4061T
- CHEBI:42265
- MFCD03791061
- CHEMBL207990
- orb1300427
- DTXCID80819894
- DOGIDQKFVLKMLQ-JTHVHQAWSA-N
- GLXC-07975
- AMX10202
- BCP13740
- EX-A1663
- IEP-4381
- JFA38121
- KS-00001D7W
- ZINC3927842
- 1756AH
- BBF-01701
- AKOS025396426
- C28-H50-N4-O7
- Epoxomicin, >=95% (HPLC), solid
- CS-3998
- S7038,BU-4061T
- CID11226684
- NCGC00389337-01
- NCGC00389337-02
- NCGC00485955-01
- CID:11226684
- DA-63239
- HY-13821
- MS-30118
- SID:53790342
- J518.990J
- A2606
- A858017
- C078846
- (2S,3S)-2-[[(2S,3S)-2-[acetyl(methyl)amino]-3-methylpentanoyl]amino]-N-[(2S,3R)-3-hydroxy-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]-3-methylpentanamide
- Q5383826
- Epoxomicin, 97%, a selective proteasome inhibitor - 1MG 1mg
- L-threoninamide, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-((1S)-3-methyl-1-(((2R)-2-methyl-2-oxiranyl)carbonyl)butyl)-
- N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-((1S)-3-methyl-1-(((2R)-2-methyl-2-oxiranyl)carbonyl)butyl)-L-threoninamide
- (2S,3S)-N-[(1S,2R)-2-hydroxy-1-{[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}propyl]-3-methyl-2-[(2S,3S)-3-methyl-2-(N-methylacetamido)pentanamido]pentanamide
- N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-(3-methyl-1-((2-methyloxiranyl)carbonyl)butyl)-L-threoninamide
- N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-threoninamide
- (2R,3S)-2-[acetyl(methyl)amino]-N-[(2S,3S)-1-{[(2S,3R)-3-hydroxy-1-({(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}amino)-1-oxobutan-2-yl]amino}-3-methyl-1-oxopentan-2-yl]-3-methylpentanamide
- (2S,3S)-2-(((2S,3S)-2-(acetyl(methyl)amino)-3-methylpentanoyl)amino)-N-((2S,3R)-3-hydroxy-1-(((2S)-4-methyl-1-((2R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxobutan-2-yl)-3-methylpentanamide
- (2S,3S)-2-[[(2S,3S)-2-[acetyl(methyl)amino]-3-methyl-pentanoyl]amino]-N-[(1S,2R)-2-hydroxy-1-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]carbamoyl]propyl]-3-methyl-pentanamide
- L-Threoninamide, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-((1S)-3-methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)-
- N-Acetyl-N-methyl-L-Ile-L-Ile-L-Thr-[(1S)-1-[[(R)-2-methyloxiranyl]carbonyl]-3-methylbutyl]NH2
- N-Acetyl-N-methyl-L-Ile-L-Ile-L-Thr-[(S)-1-[[(R)-2-methyloxiranyl]carbonyl]-3-methylbutyl]NH2
- N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-threoninamide